Axsome Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-108.2M | $-108.5M | $308.0K | $20.8M |
| FY2022 | $-116.5M | $-117.2M | $702.0K | $37.7M |
| FY2023 | $-145.1M | $-145.7M | $582.0K | $62.6M |
| FY2024 | $-128.4M | $-128.7M | $270.0K | $85.2M |
| FY2025 | $-93.4M | $-93.9M | $480.0K | $93.8M |